248 related articles for article (PubMed ID: 30594097)
1. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
[TBL] [Abstract][Full Text] [Related]
2. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
[TBL] [Abstract][Full Text] [Related]
3. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
[TBL] [Abstract][Full Text] [Related]
4. Incidence of postoperative residual neuromuscular blockade after general anesthesia: a prospective, multicenter, anesthetist-blind, observational study.
Yu B; Ouyang B; Ge S; Luo Y; Li J; Ni D; Hu S; Xu H; Liu J; Min S; Li L; Ma Z; Xie K; Miao C; Wu X;
Curr Med Res Opin; 2016; 32(1):1-9. PubMed ID: 26452561
[TBL] [Abstract][Full Text] [Related]
5. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
[TBL] [Abstract][Full Text] [Related]
6. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
[TBL] [Abstract][Full Text] [Related]
7. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
8. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis.
Fruergaard K; Viby-Mogensen J; Berg H; el-Mahdy AM
Acta Anaesthesiol Scand; 1998 Nov; 42(10):1168-74. PubMed ID: 9834799
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Residual Neuromuscular Blockade, Oversedation, and Hypothermia on Adverse Respiratory Events in a Postanesthetic Care Unit: A Prospective Study of Prevalence, Predictors, and Outcomes.
Stewart PA; Liang SS; Li QS; Huang ML; Bilgin AB; Kim D; Phillips S
Anesth Analg; 2016 Oct; 123(4):859-68. PubMed ID: 27537929
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
[TBL] [Abstract][Full Text] [Related]
11. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
[TBL] [Abstract][Full Text] [Related]
12. Observational study on patterns of neuromuscular blockade reversal.
Dubovoy T; Housey M; Devine S; Kheterpal S
BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
[TBL] [Abstract][Full Text] [Related]
13. A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
Insinga RP; Joyal C; Goyette A; Galarneau A
BMC Anesthesiol; 2016 Nov; 16(1):114. PubMed ID: 27852231
[TBL] [Abstract][Full Text] [Related]
14. Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists.
Aytac I; Postaci A; Aytac B; Sacan O; Alay GH; Celik B; Kahveci K; Dikmen B
Braz J Anesthesiol; 2016; 66(1):55-62. PubMed ID: 26768931
[TBL] [Abstract][Full Text] [Related]
15. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
[TBL] [Abstract][Full Text] [Related]
17. Residual neuromuscular blockade in the postanesthesia care unit: observational cross-sectional study of a multicenter cohort.
Errando CL; Garutti I; Mazzinari G; Díaz-Cambronero Ó; Bebawy JF;
Minerva Anestesiol; 2016 Dec; 82(12):1267-1277. PubMed ID: 27232277
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
19. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
20. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
